Clinical trial
Efficacy Study in Removing Excess Iron From the Heart
NCT00105495 · ApoPharma, Industry · Completed
Key facts
| NCT number | NCT00105495 |
|---|---|
| Title | Efficacy Study in Removing Excess Iron From the Heart |
| Official title | Randomized Trial Comparing the Relative Efficacy of Deferiprone to That of Deferoxamine in Removing Excess Cardiac Iron in Thalassemia Major Patients |
| Lead sponsor | ApoPharma, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Thalassemia Major, Hemosiderosis |
| Intervention type | Drug |
| Interventions | Ferriprox (deferiprone), Desferal (deferoxamine) |
| Enrollment | 60 |
| Start date | Dec 1, 2002 |
| Completion | Oct 1, 2004 |
| First posted | Mar 16, 2005 |
| Last update posted | Jan 5, 2016 |
| Countries | Greece, Italy |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: